Perioperative medicine & outcomes

Perioperative Management and Outcome of Catecholamine-Induced Takotsubo and Dilated Cardiomyopathy in Pheochromocytoma and Paraganglioma

J Cardiothorac Vasc AnesthPublished Retrospective cohort study

Authors' conclusion

Following the preoperative medication preparation and anti-heart failure treatment, patients with TCM had better left ventricular recovery before surgery and fewer cardiovascular risks compared to patients with DCM.

Study context

Population
Patients scheduled for elective PPGL resection with Takotsubo cardiomyopathy (TCM) or dilated cardiomyopathy (DCM), single tertiary hospital, March 2005–June 2023
Participants
29 patients
Exposure
TCM vs DCM
  • TCMn = 20
  • DCMn = 9reference
Outcome
Preoperative ejection fraction (after medication preparation and anti-HF treatment)
Follow-up
Mean preoperative
Methodological detailssingle-centre, Preoperative medication preparation 111 median days
  • Single-centre
  • Preoperative medication preparation 111 median days

Main finding

As reported in the abstract

P < 0.001

Observational data: associations, not effects.

Further findings

Tumour size and 24-hour urine norepinephrine

Bigger tumour size and higher 24-hour urine norepinephrine in DCM vs TCM

Intraoperative hemodynamic instability score (all patients)

Hemodynamic instability score (points)
84.6
Hemodynamic variables section (points)
13.7

Intraoperative hemodynamics, fluids and vasoactive agents

DCM more prone to hemodynamic disturbances, lower fluid volume but higher vasoactive infusion vs TCM

Complications and perioperative mortality (all patients)

Incidence of complications
6.9%
Perioperative mortality
0

Original publication

Perioperative Management and Outcome of Catecholamine-Induced Takotsubo and Dilated Cardiomyopathy in Pheochromocytoma and Paraganglioma. J Cardiothorac Vasc Anesth. Published 5 February 2025. doi:10.1053/j.jvca.2025.02.004

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.